Products and Services
-
Vero Biotech announced an investment of $30 million from Petrichor Healthcare Capital Management that will be used for commercialization of Vero’s Genosyl DS tankless inhaled nitric oxide system. The company recently announced that it had… Read more . . .
-
Acorda Therapeutics announced that it has signed a new supply agreement with Catalent that reduces the amount of product that the company is required to buy annually from $18 million to $8.5 million for 2023… Read more . . .
-
Florida-based CDMO Formulated Solutions announced that it has acquired a 455,000 sq ft production facility in Cleveland, TN, USA that includes two buildings fitted with pharmaceutical production and packaging lines for a variety of dose forms… Read more . . .
-
Inhaled nitric oxide (iNO) delivery device developer Third Pole Therapeutics announced that it has received a $32 million equity investment “from a large medical device innovator.” In February 2022, the company announced the closing of… Read more . . .
-
CDMO Experic, which offers development and manufacturing services for DPIs, announced that it has closed a $14 million series B funding led by East Seattle Partners and inhaler filling experts Harro Höfliger Packaging Systems. The company… Read more . . .
-
CDMO Micro-Sphere, which offers spray drying and capsule filling for DPI formulations, said that it has now added new particle engineering R&D space with FluidAir PolarDry electrostatic spray drying technology. The company recently announced the… Read more . . .
-
Adherium announced that the FDA has granted 510(k) clearance for use of Adherium’s next-generation Hailie inhaler sensor with GSK’s Ventolin, Advair, and Flovent MDIs. The company had announced submission of the 510(k) application in August… Read more . . .
-
CDMO Kindeva Drug Delivery, which specializes in inhalation, intradermal, and transdermal drug delivery, has announced that it will merge with fellow Altaris Capital Partners company Meridian Medical Technologies, which specializes in autoinjectors. Altaris acquired Kindeva… Read more . . .
-
According to modeling software company Simulations Plus, the FDA has awarded the company a contract for a project that is intended to improve models of pulmonary absorption of inhaled drugs, with a goal of creating “the… Read more . . .
-
TFF Pharmaceuticals announced that it has been working with Aptar Pharma on a project to develop dry powder vaccines based on TFF’s thin film freezing particle manufacturing platform and Aptar Pharma’s Unidose (UDS) nasal powder… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 10: SMI.London 2026, London, UK
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan